A new global report released by Research and Markets outlines the top five trends currently shaping the legal cannabis industry, highlighting both challenges and opportunities as the market continues to evolve.
According to Top Five Trends in Cannabis, the adult-use sector remains the driving force behind global cannabis growth, influencing both consumer behavior and regulatory momentum. Despite ongoing advances across the medical and CBD sectors, adult-use marijuana continues to generate the most revenue and steer broader legislative efforts.
The report warns that cannabis regulatory developments are likely to remain inconsistent and unpredictable through at least 2027, especially given broader geopolitical and economic uncertainty. Governments may deprioritize legalization, making it harder for companies to forecast and plan.
Another major trend is the proliferation of intoxicating hemp-derived cannabinoid (HDIC) products, particularly in the United States. These items—often sold in states without legal marijuana—are disrupting the legal market while also expanding access and creating new revenue streams in areas where THC products remain otherwise restricted.
The report also emphasizes a sharp increase in targeted cannabis product innovation. Companies are crafting more tailored experiences for specific consumer needs, such as sleep, relaxation or focus. This, the report suggests, is accelerating the normalization of cannabis use and drawing in a wider consumer base. Brands like Kiva’s Camino are cited for their focus on clearly defined effects and need states.
Finally, the report highlights persistent corporate challenges, especially in mature markets like the U.S. and Canada. High tax burdens, oversupply, price compression, and unclear legal frameworks have created a difficult environment for operators, though the report notes opportunities still exist for companies that can adapt.
The report offers forecasts through 2027 and includes data on market size, company and brand shares, and distribution. It covers adult-use marijuana, medical cannabis, and CBD and other non-intoxicating cannabinoids. For more information, click here.
More articles from The Marijuana Herald:
